Lectures and Presentations at Conferences and Seminars

Post Grad Dip in Oncology – Sr Terry Ventrice
Haematology Short Course –Trish Harris, Lucy Hancock
CNSA Conference – T. Harris, K. Fellenberg (poster)
18th Lorne Cancer Conference. ‘New Insights into leukaemia biology; what imatinib has taught us about CML’ Lorne Victoria February 2006
CML Therapy Management. Shanghai, China; Seoul, Korea; Taiwan, China Republic. March 2006.
European Haematology Association. CML Global Opinion Leader Summit. Rome Italy. March 2006
NDLR 2006. ‘Insights into the biology of BCR-ABL expressing leukaemias based on clinical experience with ABL kinase inhibitors’. Sunshine Coast, Queensland. April 2006
Malaysian Society of Haematology Conference. ‘Targeted therapy in haematological malignancy: what have we learnt from the imatinib experience in CML’ Malaysia. April 2006.
Novartis Investigator Meeting for TOPS and IRIS Trials. Short Hills, New Jersey, USA. May 2006.
European Haematology Association. ‘Routine cytogenetics is no longer indicated in CML’. Amsterdam, Holland June 2006
Hunter Medical Research Institute. ‘Targeting CML stem cells’ Newcastle NSW
Novartis Nilotinib Investigator Meeting. ‘Nilotinib and BCR-ABL mutations’ Paris, France
AH&MRC ‘Stem cells in CML’. Melbourne, Victoria. November 2006
ASH. ‘ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring’. Orlando, USA. December 2006
ASH Satellite Symposia. ‘Molecular monitoring in CML: targets of therapy.’ Orlando, USA. December 2006.
International Mayo Clinic State of the Art Symposium on Haematologic Malignancies’. Wellington, New Zealand. January 2007
Beverley Wake and Rebekah Treloar, HSANZ/ANZSBT/ASTH Annual Scientific Meeting, Hobart October 2006
Anne Canty, Haemophilia Nurses meeting, Melbourne, October 2006
Rebekah Treloar, Haemophilia Nurses meeting, Melbourne, October 2006
Bev Wake “Successions 2” Therapeutic Apheresis Programme / Cellular Therapy Programme, Gambro BCT, Sydney 2006